IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza Rides Biopharma Wave

1:38 PM MDT | January 31, 2007 | Alex Scott

Lonza has unveiled a robust set of 2006 results, bolstered by a substantial contribution from the company’s fast-growing biopharmaceuticals business. Lonza’s biopharma sales increased 31% last year, to SF468 million ($375 million), the company says. Growing demand and a strong project pipeline supported a number of capacity expansions and related acquisitions in the biopharma field, Lonza says. Lonza’s exclusive synthesis and biopharmaceuticals division, which includes the biopharma business, recorded a 36% increase in 2006 Ebit, to SF193...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa